Page last updated: 2024-08-24

plerixafor and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated

plerixafor has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aldoss, I; Ali, H; Cao, TM; Chen, R; Forman, SJ; Nademanee, A; Paris, T; Salhotra, A; Sanchez, JF; Shan, Y; Spielberger, R; Tsai, NC	1
Burger, JA; Ford, RJ; Kurtova, AV; Tamayo, AT	1
Gaarsdal, E; Hansen, PB	1

Trials

1 trial(s) available for plerixafor and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated

Article	Year
Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor Rescue. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:8 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autografts; Benzylamines; Cyclams; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine	2017

Article

Year

Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor Rescue.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:8

Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autografts; Benzylamines; Cyclams; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine

2017

Other Studies

2 other study(ies) available for plerixafor and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated

Article	Year
Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting. Blood, 2009, May-07, Volume: 113, Issue:19 Topics: Actins; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzylamines; Blotting, Western; Cell Adhesion; Cell Migration Inhibition; Cell Movement; Cell Survival; Chemotaxis; Cyclams; Drug Resistance, Neoplasm; Flow Cytometry; Heterocyclic Compounds; Humans; Integrin alpha4beta1; Lymphoma, Mantle-Cell; Natalizumab; Receptors, CXCR4; Receptors, CXCR5; Signal Transduction; Stromal Cells; Tumor Cells, Cultured	2009
[Stem cell harvesting after plerixafor treatment]. Ugeskrift for laeger, 2009, Nov-16, Volume: 171, Issue:47 Topics: Aged; Benzylamines; Compassionate Use Trials; Cyclams; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Lymphoma, Mantle-Cell; Male; Recombinant Proteins; Transplantation, Autologous	2009

Article

Year

Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.

Blood, 2009, May-07, Volume: 113, Issue:19

Topics: Actins; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzylamines; Blotting, Western; Cell Adhesion; Cell Migration Inhibition; Cell Movement; Cell Survival; Chemotaxis; Cyclams; Drug Resistance, Neoplasm; Flow Cytometry; Heterocyclic Compounds; Humans; Integrin alpha4beta1; Lymphoma, Mantle-Cell; Natalizumab; Receptors, CXCR4; Receptors, CXCR5; Signal Transduction; Stromal Cells; Tumor Cells, Cultured

2009

[Stem cell harvesting after plerixafor treatment].

Ugeskrift for laeger, 2009, Nov-16, Volume: 171, Issue:47

Topics: Aged; Benzylamines; Compassionate Use Trials; Cyclams; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Lymphoma, Mantle-Cell; Male; Recombinant Proteins; Transplantation, Autologous

2009